BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26236443)

  • 1. Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?
    Bobdey S; Balasubramanium G; Kumar A; Jain A
    Int J Prev Med; 2015; 6():56. PubMed ID: 26236443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of cervical cancer and role of screening in India.
    Bobdey S; Sathwara J; Jain A; Balasubramaniam G
    Indian J Med Paediatr Oncol; 2016; 37(4):278-285. PubMed ID: 28144096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
    Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
    Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.
    Adsul P; Manjunath N; Srinivas V; Arun A; Madhivanan P
    Cancer Epidemiol; 2017 Aug; 49():161-174. PubMed ID: 28704717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.
    Sankaranarayanan R; Nene BM; Dinshaw K; Rajkumar R; Shastri S; Wesley R; Basu P; Sharma R; Thara S; Budukh A; Parkin DM
    Salud Publica Mex; 2003; 45 Suppl 3():S399-407. PubMed ID: 14746033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date.
    Gaffikin L; Lauterbach M; Blumenthal PD
    Obstet Gynecol Surv; 2003 Aug; 58(8):543-50. PubMed ID: 12886165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of cervical cancer through acetic acid application--an aided visual inspection.
    Singh V; Sehgal A; Parashari A; Sodhani P; Satyanarayana L
    Singapore Med J; 2001 Aug; 42(8):351-4. PubMed ID: 11764051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstaging of cervical cancer.
    Ananth R
    J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Abnormal Cervix with Visual Inspection under Acetic Acid and Colposcopy.
    Bhattachan K; Dangal G; Karki A; Pradhan HK; Shrestha R; Parajuli S; Poudel R; Bajracharya N; Tiwari K
    J Nepal Health Res Counc; 2019 Apr; 17(1):76-79. PubMed ID: 31110381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of visual inspection with acetic acid and with Lugol's iodine for cervical cancer screening: Meta-analysis.
    Qiao L; Li B; Long M; Wang X; Wang A; Zhang G
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1313-25. PubMed ID: 26014371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.
    Saxena U; Sauvaget C; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2012; 13(4):1699-703. PubMed ID: 22799391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical assessment of screening methods for cervical neoplasia.
    Sankaranarayanan R; Gaffikin L; Jacob M; Sellors J; Robles S
    Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S4-S12. PubMed ID: 15823266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Accuracy of Papanicolaou Test Cytology, Visual Inspection With Acetic Acid, and Visual Inspection With Lugol Iodine in Screening for Cervical Neoplasia in Southeast Nigeria.
    Egede J; Ajah L; Ibekwe P; Agwu U; Nwizu E; Iyare F
    J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cervical cancer and human papilloma virus: Indian context.
    Deodhar KK
    Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in rural India: Status & current concepts.
    Srivastava AN; Misra JS; Srivastava S; Das BC; Gupta S
    Indian J Med Res; 2018 Dec; 148(6):687-696. PubMed ID: 30778002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review.
    Sritipsukho P; Thaweekul Y
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S254-61. PubMed ID: 21294423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
    Labani S; Asthana S
    J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.